Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 67Observational 3Expanded_access 1

Sponsor

Cancer Type

Sarcoma 3Gastrointestinal 3

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Neoplasms 3Leukemia, Myeloid, Chronic-Phase 3Leukemia 3Gastrointestinal Stromal Tumors 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Hematologic Neoplasms 1GIST 1

Interventions

Sunitinib 3Observation 3Imatinib Mesylate 3ripretinib 2regorafenib 2Blood Specimen Collection 2trastuzumab deruxtecan 1nilotinib 1avapritinib 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiofrequency Ablation 1Quality Assurance, Health Care 1Liquid Biopsy 1Laparoscopy 1Interviews as Topic 1High-Energy Shock Waves 1Endosonography 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Gastrointestinal Stromal Tumors × Imatinib Mesylate × Clear all
NCT05381753 2026-02-11

Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World

CStone Pharmaceuticals

Completed
61 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06038552 2025-02-26

Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM

First Affiliated Hospital, Sun Yat-Sen University

Completed
238 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06628739 2024-10-08

Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes

First Affiliated Hospital, Sun Yat-Sen University

Completed
168 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡